Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several…

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, January 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

policy: 2 policy sources

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 41 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Tiotropium bromide

Cited by Canadian Agency for Drugs and Technologies in Health on 22 May 2018

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Konsekvenser af skift af inhalator til KOL-medicin

Cited by The Danish Center for Social Science Research on 28 Feb 2017

VIVE is a research and analysis center that has some of the country's leading experts and the strongest environment for applied research and analysis in the field of welfare.

Dove Medical Press

Article Metrics